Unbound MEDLINE

Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial. Haematologica [Haematologica] Journal article

 
TitleContinuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial.
Author(s)Voskaridou E, Christoulas D, Konstantinidou M, Tsiftsakis E, Alexakos P, Terpos E 
InstitutionLaikon General Hospital, Athens, Greece; Departments of.
SourceHaematologica 2008 Aug 12.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID18698086
  
Advertise on this site.